Outlook on the Protein Expression Global Market to 2026 - Featuring Agilent Technologies, Bio-Rad Laboratories and Synthetic Genomics Among Others

News provided by

Mar 19, 2021, 09:00 ET

DUBLIN, March 19, 2021 /PRNewswire/ -- The "Protein Expression Market By Expression Systems, Product, Application, End-use and Geography (North America, Europe, APAC and RoW) - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.

The Protein Expression Market is expected to grow at a rate of 13.3% CAGR by 2026. Protein expression is a process of producing proteins that are synthesized, modified, and regulated. Protein expression includes laboratory techniques & procedures which help in the production of proteins. The process enables to generate and purify the required protein, either within the cell or outside the cell. The technique of producing synthesized proteins, utilizing the protein expression process can be generally used for industrial purposes or to diagnose and treat diseases. The protein expression market growth can be attributed to key factors such as the rapidly increasing number of chronic diseases and the increase in funding availability for research on proteins. Huge costs incurred in protein expression reagents and instruments are restricting the protein expression market growth.

In the protein expression market, according to the expression system segment, the prokaryotic is the most commonly used expression in the protein expression process which is used for the protein synthesis, modification, and regulation of proteins in living organisms. The prokaryotic expression is widely used because of the high capability of the production of proteins and low-cost production.

As per the product segmentation in the protein expression market, the service segment is projected to have the highest CAGR rate. This is due to the increasing preference for the service for custom optimization and the availability of advanced products and research professionals.

The therapeutic application has a pivotal role in the protein expression market share based on the application. An enormous increase in the prevalence of chronic diseases and increasing research and development activity is fueling market growth. Furthermore, the key factor is the wide application of protein expression in the production of biologics.

The crucial end users of the protein expression market are the pharmaceutical and biotechnological companies and also have a major share in the market. This is because of the increasing requirement of the therapeutic proteins, which includes hormones, enzymes, anticoagulants, and the increasing expenditure in novel drug development.

Accordant to the regional market, North America is having the leading share in the protein expression market. This is because this region has the highest rate of deployment of the therapeutic based on biotechnology and the high contribution of pharmaceutical companies in designing protein-based medicines.

The crucial factors involved in the growth of the global protein expression market include the increase in the elderly population due to which there is a rising incidence of chronic diseases which is a major factor of the growth. Also, the increasing demand for protein biologics is another factor that is boosting the demand for the global market of protein expression.

The significant market competitors of the protein expression market are Merck KGaA, GenScript Biotech Corporation, Agilent Technologies Inc., Bio-Rad Laboratories Inc., ProMab Biotechnologies Inc., Synthetic Genomics Inc., Lonza, Promega Corporation, Thermo Fisher Scientific Inc., Takara Bio, New England Biolabs, Oxford Expression Technologies Ltd., LifeSensors, ProteoGenix, Peak Proteins Ltd., Sino Biological Inc, and Lucigen Corporation.

Moreover, there are a number of research and developments that are continuously going on in the field of protein expression by various pharmaceutical and biopharmaceutical companies to bring advanced biologics.

This report provides insights into protein expression market trends and predictions of the future market size.
This report gives the major market dynamics and the factors affecting the protein expression market and its sub-segments.
This report also presents geographical dynamics of the protein expression market and insights into drivers and opportunities in the major regions such as North America, Europe, Asia-Pacific, and the Rest of the World.
This research presents the major shareholders, product portfolios, new developments, and the market players' competitive landscape.

Key Topics Covered:

1. Executive Summary

2. Industry Outlook
2.1. Industry Overview
2.2. Industry Trends

3. Market Snapshot
3.1. Market Definition
3.2. Market Outlook
3.2.1. PEST Analysis
3.2.2. Porter Five Forces
3.3. Related Markets

4. Market characteristics
4.1. Market Evolution
4.2. Market Trends and Impact
4.3. Advantages/Disadvantages of Market
4.4. Regulatory Impact
4.5. Market Offerings
4.6. Market Segmentation
4.7. Market Dynamics
4.7.1. Drivers
4.7.2. Restraints
4.7.3. Opportunities
4.8. DRO - Impact Analysis

5. Products: Market Size & Analysis
5.1. Overview
5.2. Prokaryotic expression systems
5.3. Mammalian cell systems
5.4. Insect cell systems
5.5. Yeast systems
5.6. Other systems

6. Component: Market Size & Analysis
6.1. Overview
6.2. Reagents
6.3. Competent cells
6.4. Expression vectors
6.5. Services
6.6. Instruments

7. Mode of Delivery: Market Size & Analysis
7.1. Overview
7.2. Therapeutic
7.3. Industrial
7.4. Research

8. End User: Market Size & Analysis
8.1. Overview
8.2. Pharmaceutical and biotechnological companies
8.3. Academic research
8.4. Contract research organizations
8.5. Others

9. Geography: Market Size & Analysis
9.1. Overview
9.2. North America
9.3. Europe
9.4. Asia Pacific
9.5. Rest of the World

10. Competitive Landscape
10.1. Competitor Comparison Analysis
10.2. Market Developments
10.2.1. Mergers and Acquisitions, Legal, Awards, Partnerships
10.2.2. Product Launches and execution

11. Vendor Profiles
11.1. Merck KGaA
11.1.1. Overview
11.1.2. Financials
11.1.3. Products/Services
11.1.4. Recent Developments
11.1.5. Business Strategy
11.2. GenScript Biotech Corporation
11.2.1. Overview
11.2.2. Financials
11.2.3. Products/Services
11.2.4. Recent Developments
11.2.5. Business Strategy
11.3. Agilent Technologies Inc
11.3.1. Overview
11.3.2. Financials
11.3.3. Products/Services
11.3.4. Recent Developments
11.3.5. Business Strategy
11.4. Bio-Rad Laboratories Inc
11.4.1. Overview
11.4.2. Financials
11.4.3. Products/Services
11.4.4. Recent Developments
11.4.5. Business Strategy
11.5. ProMab Biotechnologies Inc
11.5.1. Overview
11.5.2. Financials
11.5.3. Products/Services
11.5.4. Recent Developments
11.5.5. Business Strategy
11.6. Synthetic Genomics Inc
11.6.1. Overview
11.6.2. Financials
11.6.3. Products/Services
11.6.4. Recent Developments
11.6.5. Business Strategy
11.7. Lonza
11.7.1. Overview
11.7.2. Financials
11.7.3. Products/Services
11.7.4. Recent Developments
11.7.5. Business Strategy
11.8. Promega Corporation
11.8.1. Overview
11.8.2. Financials
11.8.3. Products/Services
11.8.4. Recent Developments
11.8.5. Business Strategy
11.9. Thermo Fisher Scientific Inc
11.9.1. Overview
11.9.2. Financials
11.9.3. Products/Services
11.9.4. Recent Developments
11.9.5. Business Strategy
11.10. Takara Bio
11.10.1. Overview
11.10.2. Financials
11.10.3. Products/Services
11.10.4. Recent Developments
11.10.5. Business Strategy

12. Companies to Watch
12.1. New England Biolabs
12.1.1. Overview
12.1.2. Product/Services
12.1.3. Business Strategy
12.2. Oxford Expression Technologies Ltd
12.2.1. Overview
12.2.2. Product/Services
12.2.3. Business Strategy
12.3. LifeSensors
12.3.1. Overview
12.3.2. Product/Services
12.3.3. Business Strategy
12.4. ProteoGenix
12.4.1. Overview
12.4.2. Product/Services
12.4.3. Business Strategy
12.5. Peak Proteins Ltd
12.5.1. Overview
12.5.2. Product/Services
12.5.3. Business Strategy
12.6. Sino Biological Inc
12.6.1. Overview
12.6.2. Product/Services
12.6.3. Business Strategy
12.7. Lucigen Corporation
12.7.1. Overview
12.7.2. Product/Services
12.7.3. Business Strategy

13. Analyst Opinion

14. Annexure
14.1. Report Scope
14.2. Market Definitions
14.3. Research Methodology
14.3.1. Data Collation and In-house Estimation
14.3.2. Market Triangulation
14.3.3. Forecasting
14.4. Report Assumptions
14.5. Declarations
14.6. Stakeholders
14.7. Abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/ypl0pm

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets